Andover House Inc. is a registered 501(c)(3) Public Charity that supports research initiatives, including contributions to open-access journals and the publication of peer-reviewed articles in the field of Precision Nanomedicine.

Home
PRNANO 6(4)
  • PRNANO_1012023
  • PRNANO_1042023
  • PRNANO_1072023
  • PRNANO_1082023
  • PRNANO_1092023
  • PRNANO_1112023
PRNANO 7
  • PRNANO_1142023
  • PRNANO_1102023
  • PRNANO_992023
  • PRNANO_1162023
  • PRNANO_1252024
  • PRNANO_1292024
  • PRNANO_1362024
  • PRNANO_1412024
  • PRNANO_1462024
  • PRNANO_1622024
  • PRNANO_1652024
  • PRNANO_1672024
  • PRNANO_1682024
  • PRNANO_1702024
PRNANO 8
  • PRNANO_1742024
  • PRNANO_1752024
  • PRNANO_1762024
  • PRNANO_2042025
  • PRNANO_1812025
  • PRNANO_1882025
  • PRNANO_1972025
  • PRNANO_2012025
  • PRNANO_2102025
  • PRNANO_2112025
  • PRNANO_2292025
  • PRNANO_2352025
  • PRNANO_2372025
  • PRNANO_2462025
Home
PRNANO 6(4)
  • PRNANO_1012023
  • PRNANO_1042023
  • PRNANO_1072023
  • PRNANO_1082023
  • PRNANO_1092023
  • PRNANO_1112023
PRNANO 7
  • PRNANO_1142023
  • PRNANO_1102023
  • PRNANO_992023
  • PRNANO_1162023
  • PRNANO_1252024
  • PRNANO_1292024
  • PRNANO_1362024
  • PRNANO_1412024
  • PRNANO_1462024
  • PRNANO_1622024
  • PRNANO_1652024
  • PRNANO_1672024
  • PRNANO_1682024
  • PRNANO_1702024
PRNANO 8
  • PRNANO_1742024
  • PRNANO_1752024
  • PRNANO_1762024
  • PRNANO_2042025
  • PRNANO_1812025
  • PRNANO_1882025
  • PRNANO_1972025
  • PRNANO_2012025
  • PRNANO_2102025
  • PRNANO_2112025
  • PRNANO_2292025
  • PRNANO_2352025
  • PRNANO_2372025
  • PRNANO_2462025
More
  • Home
  • PRNANO 6(4)
    • PRNANO_1012023
    • PRNANO_1042023
    • PRNANO_1072023
    • PRNANO_1082023
    • PRNANO_1092023
    • PRNANO_1112023
  • PRNANO 7
    • PRNANO_1142023
    • PRNANO_1102023
    • PRNANO_992023
    • PRNANO_1162023
    • PRNANO_1252024
    • PRNANO_1292024
    • PRNANO_1362024
    • PRNANO_1412024
    • PRNANO_1462024
    • PRNANO_1622024
    • PRNANO_1652024
    • PRNANO_1672024
    • PRNANO_1682024
    • PRNANO_1702024
  • PRNANO 8
    • PRNANO_1742024
    • PRNANO_1752024
    • PRNANO_1762024
    • PRNANO_2042025
    • PRNANO_1812025
    • PRNANO_1882025
    • PRNANO_1972025
    • PRNANO_2012025
    • PRNANO_2102025
    • PRNANO_2112025
    • PRNANO_2292025
    • PRNANO_2352025
    • PRNANO_2372025
    • PRNANO_2462025
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • PRNANO 6(4)
    • PRNANO_1012023
    • PRNANO_1042023
    • PRNANO_1072023
    • PRNANO_1082023
    • PRNANO_1092023
    • PRNANO_1112023
  • PRNANO 7
    • PRNANO_1142023
    • PRNANO_1102023
    • PRNANO_992023
    • PRNANO_1162023
    • PRNANO_1252024
    • PRNANO_1292024
    • PRNANO_1362024
    • PRNANO_1412024
    • PRNANO_1462024
    • PRNANO_1622024
    • PRNANO_1652024
    • PRNANO_1672024
    • PRNANO_1682024
    • PRNANO_1702024
  • PRNANO 8
    • PRNANO_1742024
    • PRNANO_1752024
    • PRNANO_1762024
    • PRNANO_2042025
    • PRNANO_1812025
    • PRNANO_1882025
    • PRNANO_1972025
    • PRNANO_2012025
    • PRNANO_2102025
    • PRNANO_2112025
    • PRNANO_2292025
    • PRNANO_2352025
    • PRNANO_2372025
    • PRNANO_2462025

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

Communication

Kalo, Eyal, Keith Nelson, Yael Shilo-Benjamini, Alex Wajnerman, Nissim Vasilevski, Orna Hifi, Dinorah Barasch, Perri Rozenberg-Hasson, Ahuva Cern, and Yechezkel Barenholz

 “Liposomal-Cannabidiol Injection; Preliminary Insights into Pharmacokinetics and Safety Characteristics in Göttingen Minipigs and Rabbits.” 

Precision Nanomedicine 2025, 8 (3): 1525–41. 

Read the article

Copyright © 2025 Andoverhouse.org - All Rights Reserved.


Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept